How to become rich with ASX shares over the next 10 years

Investing for the next 10 years is very different from investing for the next 10 months.

Over a decade, short-term market moves, interest rate speculation, and daily headlines fade into the background. What matters far more is owning the right businesses, staying invested through cycles, and allowing compounding to do its work.

If I were investing on the ASX with a clear 10-year horizon, this is how I would approach it.

Start with a long-term mindset

The biggest mistake investors make is letting short-term expectations drive long-term decisions.

Over the next decade, there will almost certainly be recessions, rallies, corrections, and periods of uncertainty. None of these are reasons to abandon a long-term plan. In fact, they are part of the reason long-term investing works at all.

Instead of asking where the market is heading next, I would focus on what the world is likely to need more of in 10 years’ time. Healthcare, digital infrastructure, software, logistics, and essential services are far easier to forecast than the next market swing.

Build around high-quality ASX shares

For a 10-year timeframe, quality matters most.

High-quality businesses tend to have sustainable competitive advantages, pricing power, robust balance sheets, and talented management teams. These traits help companies adapt as conditions change.

On the ASX, examples of businesses with these characteristics include global healthcare leaders like CSL Ltd (ASX: CSL) and ResMed Inc. (ASX: RMD), infrastructure-linked compounders such as Goodman Group (ASX: GMG), and software businesses with recurring revenue like TechnologyOne Ltd (ASX: TNE) and Xero Ltd (ASX: XRO).

You do not need a large number of stocks. A focused portfolio of quality businesses you understand well is often easier to hold through volatility than a long list of ideas.

Time in the market

Over 10 years, the biggest advantage an investor has is time.

Regular investing smooths out market ups and downs and reduces the pressure to time entries perfectly through dollar-cost averaging. Whether you are investing monthly, quarterly, or when cash becomes available, consistency matters more than precision.

Importantly, staying invested allows compounding to work uninterrupted. Interrupting that process by jumping in and out of the market can significantly reduce long-term returns.

For example, by investing $1,000 a month into ASX shares and achieving an average total return of 10% per annum, you could grow your portfolio to $200,000 in 10 years.

Reinvest and review

For most of the next decade, reinvestment should be the default.

Dividends that are reinvested buy more ASX shares, which generate more dividends, which then compound further. This flywheel effect becomes increasingly powerful over time.

This isn’t necessarily set and forget, investors ought to review their holdings periodically. I would focus on whether the underlying businesses are still executing, not whether the share price has moved recently. Selling decisions should be driven by fundamentals.

Foolish takeaway

Investing on the ASX for the next 10 years is not about predicting the future. It is about positioning for it.

By focusing on high-quality businesses, staying consistent, reinvesting returns, and resisting the urge to react to short-term noise, investors give themselves the best chance of benefiting from long-term compounding.

The post How to become rich with ASX shares over the next 10 years appeared first on The Motley Fool Australia.

More reading

• Here are my top 10 ASX stocks for 2026
• Buy, hold, sell: CBA, CSL, and DroneShield shares
• 10 ASX shares I’d buy with $10,000 in 2026 to beat the market
• How to build a $250,000 ASX share portfolio starting at zero
• Top Australian stocks to buy with $5,000 in 2026

Motley Fool contributor James Mickleboro has positions in CSL, Goodman Group, ResMed, Technology One, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goodman Group, ResMed, Technology One, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended CSL, Goodman Group, and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.